Cite
HARVARD Citation
Saito, T. et al. (2019). Malignancy Index Using Intraoperative Flow Cytometry is a Valuable Prognostic Factor for Glioblastoma Treated With Radiotherapy and Concomitant Temozolomide. Neurosurgery. 84 (3), pp. 662-672. [Online].